Compare NXL & CLWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NXL | CLWT |
|---|---|---|
| Founded | 2010 | 1971 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Professional and commerical equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 8.8M |
| IPO Year | 2022 | 1996 |
| Metric | NXL | CLWT |
|---|---|---|
| Price | $1.47 | $1.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 29.8K | ★ 36.2K |
| Earning Date | 11-12-2026 | 12-29-2026 |
| Dividend Yield | N/A | ★ 11.59% |
| EPS Growth | ★ 39.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $301,647.00 | N/A |
| Revenue This Year | $14.37 | N/A |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | ★ N/A | $17.56 |
| Revenue Growth | ★ 78.78 | N/A |
| 52 Week Low | $0.22 | $0.99 |
| 52 Week High | $67.20 | $2.68 |
| Indicator | NXL | CLWT |
|---|---|---|
| Relative Strength Index (RSI) | 34.55 | 43.92 |
| Support Level | $1.31 | $1.12 |
| Resistance Level | $5.36 | $1.36 |
| Average True Range (ATR) | 0.15 | 0.07 |
| MACD | 0.17 | -0.01 |
| Stochastic Oscillator | 64.29 | 32.14 |
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.
Euro Tech Holdings Co Ltd is mainly a distributor of a wide range of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies, and power generation equipment, including recorders and power quality analyzers. The Company acts as an exclusive or non-exclusive distributor for manufacturers of such equipment to commercial customers and governmental agencies in Hong Kong and mainland China, as well as commercial customers in Macau. It has two operating segments: Trading and manufacturing, which generate maximum revenue and act as a distributor of water treatment equipment, laboratory instruments, analyzers, test kits, related supplies, and power generation equipment; and the Engineering segment. The Company generates maximum revenue from the PRC.